A new demography and aging population, chronic diseases, increased competition, as well as budget constraints demand innovative therapies, pharmaceuticals, medical devices and services. It is crucial for managers in pharmaceutical and medical organizations to gain an in-depth understanding and knowledge of value creation. The "MBA Specialization Biotech, Pharma & MedTech Management" builds on a solid theoretical framework complemented by case studies, excursions and discussions with peers.

Info-Session (German)

At our info sessions, the individual study programs are presented in detail. We are happy to answer your questions and look forward to meeting you there!

Appointments

27.03.2024, 14:00

Any Question?

Please feel free to contact us directly.

Benefit from our Study Program

  • Our state-of the art specialized MBA program has allowed us to instill an enterprising culture into our modules with a strong practical orientation.
  • Our MBA offers management training that promotes students' professional and personal development and enables them to acquire the skills required to take on management roles.
  • In addition to the special features of the pharmaceutical and medical device industry, current challenges, such as the disruption of supply chains or process changes due to big data and digitalization, are discussed and innovative solutions are developed.
  • Working in small groups offers the opportunity to directly transfer the knowledge and experience of our lecturers - all international experts in their field - and colleagues. Graduates of the program are part of a network of successful innovators and entrepreneurs.
  • trending topic

  • international

  • networking

Our MBA programs fulfil highest quality standards!

The programs are internationally accredited by ACBSP. Danube Business School is member of the PRME initiative of the United Nations.

ACBSP PRME

Option Blended Learning

  • General Management Core Curriculum (Blended Learning)
  • Specialization (Blended Learning)

Continuing education tuition fee : EUR 23.900,--

Option Distance Learning (German only)

  • General Management Core Curriculum (Distance Learning)
  • Specialization (Blended Learning)

Continuing education tuition fee : EUR 16.900,-

The part time variant lasts four semesters, the full time variant three semesters.

Structur

The MBA Biotech, Pharma & MedTech Management comprises a total of 90 ECTS credits:

  • General Management Core Curriculum (51 ECTS)
    • 12 compulsory modules (36 ECTS)
    • 3-5 elective modules (15 ECTS)
  • Specialization modules (24 ECTS)
  • MBA Thesis (15 ECTS)

The Core Curriculum is offered as online distance learning variant (German only) or as blended learning variant (German or English), the Specialization is exclusively organized in English language as blended learning variant every two years. The Core Curriculum can be started at any time.

Subjects

ECTS

Subjects

ECTS

The program consists of 4 modules:

  • Contents

    • Health Care Markets I
    • Health Care Markets II
    • Compliance & Governance
    • Supply Chain Management
  • Contents

    • Quality Management & Lean Management
    • Intellectual Properties Management
    • Regulatory Affairs
    • GMP/GLP/GDP/GCP
  • Contents

    • Digitalization in Health Care
    • Big Data Management and Precision Medicine
    • R&D Strategies
    • Technology Transfer
  • Contents

    • Digitalization in Health Care
    • Big Data Management and Precision Medicine
    • R&D Strategies
    • Technology Transfer

Here, you find further information about the MBA Biotech, Pharma & MedTech Management.

Admission Requirements

  1. Relevant Austrian degree (bachelor or higher with at least 180 ECTS credits) or equivalent degree of a foreign university, and
  2. Minimum of two years of relevant professional experience in the field, and
  3. English language skills C1 and
  4. Positive completion of the admission interview and selection procedure.

Application Process

  1. Contact us to clarify your expectations of your study and fulfilment of the admission requirements
  2. Online application (enter study identification number UM 999 071 in the online tool)
  3. Please also complete and upload the required document "Learning Agreement". You can find the form in the download area.
  4. Carrying out the selection procedure (interview with the study program director)
  5. Admission to the MBA Biotech, Pharma & MedTech Management

We look forward to receiving your application and to welcoming you soon at the University for Continuing Education Krems.

Back to top